Leadership Announcement

We are thrilled to welcome Dr. William Heath to Persephoni BioPartners as our new Chief Scientific Officer.

Dr. Heath earned a Ph.D. in Biochemistry from The Rockefeller University, followed by postdoctoral studies at Harvard Medical School. His professional career began at Eli Lilly in 1988, where he played a pivotal role in transforming the company into a leader in biotherapeutics and streamlined R&D approaches. His strategic vision and leadership were instrumental in launching multiple medicines and advancing the company's research and development capabilities.

As a Group Vice President in Lilly Research Laboratories, Dr. Heath led a multi-site global team focused on the discovery, development, and commercialization of small molecules, peptides, biologics, and genetic medicines across various therapeutic areas. His passion for science and dedication to improving patient lives have been the driving force behind his successful career.

“I am delighted to join the talented team at Persephoni where together we will collaborate with inventors to bring their ideas to life. All too often, great ideas from academia fail to reach their full potential because innovators lack the experience and resources for the next steps. The Persephoni team will remove those barriers and help guide those efforts to meaningful outcomes."

Dr. Heath is also deeply committed to fostering an environment that values diversity, equity, and inclusion. He has a strong history of mentoring and developing top talent, guiding individuals to achieve their best throughout their careers.

"Given my extensive experience in working with discovery and development scientists to mature early ideas to become new medicines across multiple therapeutic areas, I see my role to also be one of mentor and coach for the next generation of innovators who will make a difference in the lives of patients. I am honored to be part of that effort.”

We are confident that Dr. Heath's expertise and leadership will be invaluable as we innovate and grow. Dr. Heath will lead our portfolio selection, development planning, management, and strategic partnerships. Please join us in extending a warm welcome to Dr. William Heath. We look forward to achieving great things together.

Persephoni BioPartners